237 related articles for article (PubMed ID: 18588953)
21. L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors.
Sbrenna S; Marti M; Morari M; Calo G; Guerrini R; Beani L; Bianchi C
J Pharmacol Exp Ther; 1999 Dec; 291(3):1365-71. PubMed ID: 10565862
[TBL] [Abstract][Full Text] [Related]
22. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities.
Reinscheid RK; Higelin J; Henningsen RA; Monsma FJ; Civelli O
J Biol Chem; 1998 Jan; 273(3):1490-5. PubMed ID: 9430687
[TBL] [Abstract][Full Text] [Related]
23. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
[TBL] [Abstract][Full Text] [Related]
24. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
Cinar R; Szücs M
J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
[TBL] [Abstract][Full Text] [Related]
25. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
Bojnik E; Babos F; Fischetti C; Magyar A; Camarda V; Borsodi A; Bajusz S; Calo' G; Benyhe S
Brain Res Bull; 2010 Mar; 81(4-5):477-83. PubMed ID: 19800951
[TBL] [Abstract][Full Text] [Related]
26. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
[TBL] [Abstract][Full Text] [Related]
27. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
Xie H; Woods JH; Traynor JR; Ko MC
Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
[TBL] [Abstract][Full Text] [Related]
28. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.
Al-Khrasani M; Orosz G; Kocsis L; Farkas V; Magyar A; Lengyel I; Benyhe S; Borsodi A; Rónai AZ
Eur J Pharmacol; 2001 Jun; 421(1):61-7. PubMed ID: 11408050
[TBL] [Abstract][Full Text] [Related]
29. Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2.
Monory K; Bourin MC; Spetea M; Tömböly C; Tóth G; Matthes HW; Kieffer BL; Hanoune J; Borsodi A
Eur J Neurosci; 2000 Feb; 12(2):577-84. PubMed ID: 10712637
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and binding activity of endomorphin-1 analogues containing beta-amino acids.
Cardillo G; Gentilucci L; Melchiorre P; Spampinato S
Bioorg Med Chem Lett; 2000 Dec; 10(24):2755-8. PubMed ID: 11133084
[TBL] [Abstract][Full Text] [Related]
31. G protein activation by endomorphins in the mouse periaqueductal gray matter.
Narita M; Mizoguchi H; Narita M; Dun NJ; Hwang BH; Endoh T; Suzuki T; Nagase H; Suzuki T; Tseng LF
J Biomed Sci; 2000; 7(3):221-5. PubMed ID: 10810240
[TBL] [Abstract][Full Text] [Related]
32. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
Zaveri NT; Journigan VB; Polgar WE
ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
[TBL] [Abstract][Full Text] [Related]
33. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A.
Lapalu S; Moisand C; Butour JL; Mollereau C; Meunier JC
FEBS Lett; 1998 May; 427(2):296-300. PubMed ID: 9607332
[TBL] [Abstract][Full Text] [Related]
34. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
35. Endomorphin-1: induction of motor behavior and lack of receptor desensitization.
Mehta A; Bot G; Reisine T; Chesselet MF
J Neurosci; 2001 Jun; 21(12):4436-42. PubMed ID: 11404430
[TBL] [Abstract][Full Text] [Related]
36. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
[TBL] [Abstract][Full Text] [Related]
37. Possible involvement of dynorphin A-(1-17) release via mu1-opioid receptors in spinal antinociception by endomorphin-2.
Mizoguchi H; Watanabe H; Hayashi T; Sakurada W; Sawai T; Fujimura T; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2006 Apr; 317(1):362-8. PubMed ID: 16394196
[TBL] [Abstract][Full Text] [Related]
38. DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
Minami M; Onogi T; Nakagawa T; Katao Y; Aoki Y; Katsumata S; Satoh M
FEBS Lett; 1995 May; 364(1):23-7. PubMed ID: 7750536
[TBL] [Abstract][Full Text] [Related]
39. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
[TBL] [Abstract][Full Text] [Related]
40. Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library.
Becker JA; Wallace A; Garzon A; Ingallinella P; Bianchi E; Cortese R; Simonin F; Kieffer BL; Pessi A
J Biol Chem; 1999 Sep; 274(39):27513-22. PubMed ID: 10488086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
